Compare MRVI & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRVI | HAFC |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 915.9M |
| IPO Year | 2020 | 2000 |
| Metric | MRVI | HAFC |
|---|---|---|
| Price | $8.17 | $32.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | $8.50 | ★ $34.25 |
| AVG Volume (30 Days) | ★ 2.4M | 174.9K |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | 14.29 | ★ 22.44 |
| EPS | N/A | ★ 1.54 |
| Revenue | $185,743,000.00 | ★ $270,165,000.00 |
| Revenue This Year | $14.01 | $9.67 |
| Revenue Next Year | $6.20 | $5.82 |
| P/E Ratio | ★ N/A | $21.07 |
| Revenue Growth | N/A | ★ 15.28 |
| 52 Week Low | $2.55 | $24.54 |
| 52 Week High | $9.42 | $33.50 |
| Indicator | MRVI | HAFC |
|---|---|---|
| Relative Strength Index (RSI) | 60.70 | 62.37 |
| Support Level | $5.54 | $30.29 |
| Resistance Level | $8.74 | $32.66 |
| Average True Range (ATR) | 0.47 | 0.54 |
| MACD | 0.08 | 0.17 |
| Stochastic Oscillator | 98.95 | 89.00 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.